Anesiva's first product launch, Zingo
This article was originally published in Scrip
Executive Summary
The US biopharmaceutical firm Anesivahas launched its needle-free intradermal lidocaine system, Zingo, in the US, for reducing pain associated with taking blood and inserting iv lines in children aged three to 18 years. It is the company's first product launch.